From Whiteboard to Reality – How the Start-up Bioanalytical CRO Pushes the Boundaries to Hit the Ground Running

logolockup.alt.small.KRegulatory requirements for the bioanalytical CRO are complex and continuously evolving. CRO start-ups need to be nimble and responsive to sponsors’ expectations in this field, which requires foresight, innovation and the willingness to adopt new approaches to meet these demands. With the ever-present restructuring, downsizing and outsourcing in the Pharma industry, leading scientists are spinning out and bringing new energy and vision to the business-as-usual mindset. In this webinar, Liz Thomas and Sally Hannam will discuss:

  • Their journey in founding Alderley Analytical, a bespoke bioanalytical CRO located in the BioHub facilities at Alderley Park in Cheshire, UK;
  • What is entailed in bringing the company to GLP compliance;
  • How their extensive experience in both large and small Pharma and CROs has paved the way to get here.

What will you learn:

  • Challenges of getting a bespoke bioanalytical CRO off the ground
  • Strategies for customizing regulated workflows for quantitative mass spectrometry
  • New perspectives for negotiating the minefield of regulatory requirements
  • Why the bioanalytical CRO partnership with Waters works.

Who attended:

  • Pharmaceutical and CRO Directors, Scientists and Laboratory Managers focused on small and large molecules in regulated bioanalysis
  • Entrepreneurial-minded scientists
  • Anyone looking to expand or invest in a new lab.

Speakers:

Liz Thomas

Elizabeth (Liz) Thomas
Co-Founder and CEO
Alderley Analytical Ltd

 

Sally Hannam

Sally Hannam
Co-Founder and Director of Science
Alderley Analytical Ltd